TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 101 filers reported holding TANGO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,740,678 | +259.9% | 953,879 | +6.1% | 0.00% | – |
| Q2 2023 | $2,984,477 | -8.0% | 898,939 | +9.4% | 0.00% | – |
| Q1 2023 | $3,245,040 | -73.5% | 821,529 | -51.3% | 0.00% | – |
| Q4 2022 | $12,236,100 | +287.3% | 1,687,738 | +93.4% | 0.00% | – |
| Q3 2022 | $3,159,000 | -6.1% | 872,602 | +17.5% | 0.00% | – |
| Q2 2022 | $3,363,000 | +79.6% | 742,336 | +200.4% | 0.00% | – |
| Q1 2022 | $1,873,000 | -25.6% | 247,134 | +7.5% | 0.00% | – |
| Q4 2021 | $2,516,000 | -1.8% | 229,993 | +16.1% | 0.00% | – |
| Q3 2021 | $2,561,000 | – | 198,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $87,719,000 | 57.68% |
| TCG Crossover Management, LLC | 1,172,250 | $5,310,000 | 2.26% |
| Boxer Capital, LLC | 6,871,642 | $31,129,000 | 1.97% |
| Cormorant Asset Management, LP | 4,507,843 | $20,421,000 | 1.54% |
| Casdin Capital, LLC | 3,500,000 | $15,855,000 | 1.34% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $8,706,000 | 1.02% |
| Samsara BioCapital, LLC | 630,000 | $2,854,000 | 0.76% |
| Southpoint Capital Advisors LP | 4,500,000 | $20,385,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 708,385 | $3,209,000 | 0.37% |
| EcoR1 Capital, LLC | 2,302,065 | $10,428,000 | 0.36% |